Advantage Alpha Capital Partners LP Veracyte, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $515 Million
- Q1 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Veracyte, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 50,534 shares of VCYT stock, worth $1.07 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
50,534
Previous 46,125
9.56%
Holding current value
$1.07 Million
Previous $1.27 Million
11.75%
% of portfolio
0.22%
Previous 0.24%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
257Shares Held
81.7MCall Options Held
43KPut Options Held
82K-
Vanguard Group Inc Valley Forge, PA7.38MShares$157 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.37MShares$157 Million0.03% of portfolio
-
Black Rock Inc. New York, NY7.21MShares$153 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.04MShares$150 Million1.11% of portfolio
-
State Street Corp Boston, MA4.33MShares$92 Million0.0% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.52B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...